{
    "medicine_id": "0f96d0ffe14d3443b255238a2a138ff0b3f449da",
    "platform_id": "DB13967",
    "metadata": {
        "name": "Patent Blue Sodium Injection 2 5 g 100mL Injection solution",
        "composition": "2 5 g 100mL Patent Blue",
        "clinical_particulars": {
            "therapeutic_indications": "Patent blue is used for marking lymphatic vessels and arterial territories as well as for sentinel lymph node prior to biopsy in patients with operable breast cancer and clinically negative lymph nodes in combination with a radiotracer A32575 Patent blue is also used in the textile paper agriculture and cosmetic industry A32574",
            "contraindications": {
                "disease": "Overdose studies have not been performed but major cases of hypersensitivity have been reported L2326",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Administration of patent blue has been reported to cause hypersensitivity reactions in approximately 1 of the patients It also presents a localized blue coloration which has made patent blue a sensitive and specific option for the detection of micrometastatic cancer in lymph nodes A32580",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Esmolol"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Atenolol"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Timolol"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Sotalol"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Propranolol"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Labetalol"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Alprenolol"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Pindolol"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Nadolol"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Bevantolol"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Practolol"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Penbutolol"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Dexpropranolol"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Celiprolol"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Nebivolol"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Bufuralol"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Bopindolol"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Indenolol"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Arotinolol"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Levobetaxolol"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Talinolol"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Anisodamine"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Bucindolol"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Esatenolol"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Cloranolol"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Mepindolol"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Epanolol"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Tertatolol"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Landiolol"
                    },
                    {
                        "drugbank-id": "DB00067",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Vasopressin"
                    },
                    {
                        "drugbank-id": "DB00093",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Felypressin"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Midodrine"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Methysergide"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Norepinephrine"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Phenylephrine"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Phenylpropanolamine"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Metaraminol"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Epinephrine"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Sumatriptan"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Ergotamine"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Methoxamine"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Pseudoephedrine"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Oxymetazoline"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Naratriptan"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Ephedrine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Mephentermine"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with S Ethylisothiourea"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB02860",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Calyculin A"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Levonordefrin"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Naphazoline"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Tetryzoline"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Etilefrine"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Cirazoline"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Synephrine"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Racepinephrine"
                    },
                    {
                        "drugbank-id": "DB11842",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Angiotensin II"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Octopamine"
                    },
                    {
                        "drugbank-id": "DB13394",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Adrenalone"
                    },
                    {
                        "drugbank-id": "DB13464",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Ornipressin"
                    },
                    {
                        "drugbank-id": "DB13517",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Angiotensinamide"
                    },
                    {
                        "drugbank-id": "DB14642",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Lypressin"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The therapeutic efficacy of Sildenafil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The therapeutic efficacy of Citalopram can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The therapeutic efficacy of Pregabalin can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "The therapeutic efficacy of Milrinone can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The therapeutic efficacy of Ranolazine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The therapeutic efficacy of Anagrelide can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The therapeutic efficacy of Isradipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The therapeutic efficacy of Theophylline can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The therapeutic efficacy of Diltiazem can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "The therapeutic efficacy of Minoxidil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The therapeutic efficacy of Treprostinil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "The therapeutic efficacy of Amlodipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The therapeutic efficacy of Nimodipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "The therapeutic efficacy of Nitric Oxide can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "The therapeutic efficacy of Prazosin can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "The therapeutic efficacy of Bosentan can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The therapeutic efficacy of Cinnarizine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The therapeutic efficacy of Nicardipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The therapeutic efficacy of Niacin can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The therapeutic efficacy of Adenosine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "The therapeutic efficacy of Dyphylline can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The therapeutic efficacy of Verapamil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "The therapeutic efficacy of Phentolamine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "The therapeutic efficacy of Nicergoline can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00770",
                        "description": "The therapeutic efficacy of Alprostadil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "The therapeutic efficacy of Tolazoline can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "The therapeutic efficacy of Fenoldopam can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The therapeutic efficacy of Pentoxifylline can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "The therapeutic efficacy of Tadalafil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The therapeutic efficacy of Levomenthol can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The therapeutic efficacy of Vardenafil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00883",
                        "description": "The therapeutic efficacy of Isosorbide dinitrate can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The therapeutic efficacy of Levosimendan can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The therapeutic efficacy of Dipyridamole can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "The therapeutic efficacy of Isosorbide mononitrate can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The therapeutic efficacy of Felodipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The therapeutic efficacy of Perhexiline can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The therapeutic efficacy of Iloprost can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The therapeutic efficacy of Papaverine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The therapeutic efficacy of Nifedipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "The therapeutic efficacy of Trimethaphan can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The therapeutic efficacy of Amiodarone can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "The therapeutic efficacy of Diazoxide can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The therapeutic efficacy of Cilostazol can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The therapeutic efficacy of Ketamine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The therapeutic efficacy of Bepridil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "The therapeutic efficacy of Hydralazine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The therapeutic efficacy of Mibefradil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "The therapeutic efficacy of Theobromine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01427",
                        "description": "The therapeutic efficacy of Amrinone can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01612",
                        "description": "The therapeutic efficacy of Amyl Nitrite can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01613",
                        "description": "The therapeutic efficacy of Erythrityl tetranitrate can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB02587",
                        "description": "The therapeutic efficacy of Colforsin can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The therapeutic efficacy of Resveratrol can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB03128",
                        "description": "The therapeutic efficacy of Acetylcholine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB04145",
                        "description": "The therapeutic efficacy of Nicotinyl alcohol can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB04513",
                        "description": "The therapeutic efficacy of N 6 Aminohexyl 5 Chloro 1 Naphthalenesulfonamide can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The therapeutic efficacy of Prenylamine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The therapeutic efficacy of Flunarizine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB04863",
                        "description": "The therapeutic efficacy of Lefradafiban can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB04880",
                        "description": "The therapeutic efficacy of Enoximone can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The therapeutic efficacy of Clevidipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The therapeutic efficacy of Beraprost can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The therapeutic efficacy of Ibudilast can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB05306",
                        "description": "The therapeutic efficacy of Alferminogene tadenovec can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "The therapeutic efficacy of Seletracetam can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The therapeutic efficacy of Nylidrin can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06154",
                        "description": "The therapeutic efficacy of Pentaerythritol tetranitrate can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06237",
                        "description": "The therapeutic efficacy of Avanafil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06267",
                        "description": "The therapeutic efficacy of Udenafil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The therapeutic efficacy of Ziconotide can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06379",
                        "description": "The therapeutic efficacy of Calcitonin gene related peptide can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The therapeutic efficacy of Dotarizine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06558",
                        "description": "The therapeutic efficacy of Tezosentan can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06698",
                        "description": "The therapeutic efficacy of Betahistine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The therapeutic efficacy of Nilvadipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06751",
                        "description": "The therapeutic efficacy of Drotaverine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "The therapeutic efficacy of Pinacidil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB08162",
                        "description": "The therapeutic efficacy of Fasudil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "The therapeutic efficacy of Agmatine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "The therapeutic efficacy of Riociguat can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "The therapeutic efficacy of Macitentan can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB08949",
                        "description": "The therapeutic efficacy of Inositol nicotinate can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The therapeutic efficacy of Fendiline can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The therapeutic efficacy of Eperisone can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09069",
                        "description": "The therapeutic efficacy of Trimetazidine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The therapeutic efficacy of Pinaverium can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09092",
                        "description": "The therapeutic efficacy of Xanthinol can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "The therapeutic efficacy of Moxisylyte can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "The therapeutic efficacy of Trimazosin can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "The therapeutic efficacy of Nicorandil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "The therapeutic efficacy of Barnidipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The therapeutic efficacy of Aranidipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "The therapeutic efficacy of Azelnidipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The therapeutic efficacy of Benidipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "The therapeutic efficacy of Cilnidipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "The therapeutic efficacy of Darodipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The therapeutic efficacy of Efonidipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The therapeutic efficacy of Lacidipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The therapeutic efficacy of Manidipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The therapeutic efficacy of Niguldipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "The therapeutic efficacy of Niludipine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The therapeutic efficacy of Doxofylline can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09282",
                        "description": "The therapeutic efficacy of Molsidomine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09283",
                        "description": "The therapeutic efficacy of Trapidil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09284",
                        "description": "The therapeutic efficacy of Imolamine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "The therapeutic efficacy of Isosorbide can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The therapeutic efficacy of Selexipag can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "The therapeutic efficacy of Angiotensin 1 7 can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB11792",
                        "description": "The therapeutic efficacy of Mirodenafil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "The therapeutic efficacy of Fostamatinib can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The therapeutic efficacy of Naftopidil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The therapeutic efficacy of Tetrahydropalmatine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB12123",
                        "description": "The therapeutic efficacy of Cinepazide can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB12126",
                        "description": "The therapeutic efficacy of Bradykinin can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The therapeutic efficacy of Vinpocetine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The therapeutic efficacy of Simendan can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB12290",
                        "description": "The therapeutic efficacy of Puerarin can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The therapeutic efficacy of Dopexamine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The therapeutic efficacy of Urapidil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The therapeutic efficacy of Gallopamil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB12926",
                        "description": "The therapeutic efficacy of Cafedrine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13203",
                        "description": "The therapeutic efficacy of Bamifylline can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13206",
                        "description": "The therapeutic efficacy of Bamethan can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13228",
                        "description": "The therapeutic efficacy of Flosequinan can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13255",
                        "description": "The therapeutic efficacy of Propatyl nitrate can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13265",
                        "description": "The therapeutic efficacy of Hexobendine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13279",
                        "description": "The therapeutic efficacy of Carbocromen can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13340",
                        "description": "The therapeutic efficacy of Suloctidil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "The therapeutic efficacy of Vincamine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "The therapeutic efficacy of Dihydroergocryptine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The therapeutic efficacy of Oxyfedrine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "The therapeutic efficacy of Linsidomine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13408",
                        "description": "The therapeutic efficacy of Methylpropylpropanediol dinitrate can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13422",
                        "description": "The therapeutic efficacy of Nicofuranose can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "The therapeutic efficacy of Endralazine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "The therapeutic efficacy of Cadralazine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The therapeutic efficacy of Bencyclane can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The therapeutic efficacy of Otilonium can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The therapeutic efficacy of Buflomedil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The therapeutic efficacy of Naftidrofuryl can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13637",
                        "description": "The therapeutic efficacy of Tenitramine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13681",
                        "description": "The therapeutic efficacy of Butalamine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13715",
                        "description": "The therapeutic efficacy of Dilazep can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13719",
                        "description": "The therapeutic efficacy of Trolnitrate can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The therapeutic efficacy of Terodiline can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13753",
                        "description": "The therapeutic efficacy of Cetiedil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The therapeutic efficacy of Lidoflazine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13793",
                        "description": "The therapeutic efficacy of Vinburnine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13812",
                        "description": "The therapeutic efficacy of Bufylline can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "The therapeutic efficacy of Caroverine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13845",
                        "description": "The therapeutic efficacy of Etafenone can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13961",
                        "description": "The therapeutic efficacy of Fish oil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB14049",
                        "description": "The therapeutic efficacy of Nitrate can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The therapeutic efficacy of Dexverapamil can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "The risk or severity of adverse effects can be increased when Ramipril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "The risk or severity of adverse effects can be increased when Fosinopril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "The risk or severity of adverse effects can be increased when Trandolapril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "The risk or severity of adverse effects can be increased when Benazepril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The risk or severity of adverse effects can be increased when Enalapril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of adverse effects can be increased when Moexipril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "The risk or severity of adverse effects can be increased when Lisinopril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "The risk or severity of adverse effects can be increased when Perindopril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "The risk or severity of adverse effects can be increased when Quinapril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of adverse effects can be increased when Omapatrilat is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of adverse effects can be increased when Rescinnamine is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "The risk or severity of adverse effects can be increased when Captopril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "The risk or severity of adverse effects can be increased when Cilazapril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "The risk or severity of adverse effects can be increased when Spirapril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "The risk or severity of adverse effects can be increased when Temocapril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "The risk or severity of adverse effects can be increased when Enalaprilat is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "The risk or severity of adverse effects can be increased when Imidapril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "The risk or severity of adverse effects can be increased when Zofenopril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "The risk or severity of adverse effects can be increased when Delapril is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "The risk or severity of adverse effects can be increased when Benazeprilat is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "The risk or severity of adverse effects can be increased when Fosinoprilat is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "The risk or severity of adverse effects can be increased when Ramiprilat is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB14209",
                        "description": "The risk or severity of adverse effects can be increased when Trandolaprilat is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB14210",
                        "description": "The risk or severity of adverse effects can be increased when Moexiprilat is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "The risk or severity of adverse effects can be increased when Perindoprilat is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "The risk or severity of adverse effects can be increased when Quinaprilat is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of adverse effects can be increased when Quinoline Yellow WS is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB15565",
                        "description": "The risk or severity of adverse effects can be increased when Cilazaprilat is combined with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01342",
                        "description": "The therapeutic efficacy of Forasartan can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "The therapeutic efficacy of Saprisartan can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01349",
                        "description": "The therapeutic efficacy of Tasosartan can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "The therapeutic efficacy of Saralasin can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "Cyclosporine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "Icosapent may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "Cefotiam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "Mesalazine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00267",
                        "description": "Cefmenoxime may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00274",
                        "description": "Cefmetazole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "Pamidronic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "Tenofovir disoproxil may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "Indomethacin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00369",
                        "description": "Cidofovir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "Triamterene may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00430",
                        "description": "Cefpiramide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "Ceftazidime may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00447",
                        "description": "Loracarbef may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "Cefalotin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "Nabumetone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "Ketorolac may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "Tenoxicam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "Celecoxib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "Cefotaxime may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "Tolmetin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "Foscarnet may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "Rofecoxib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "Piroxicam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "Methotrexate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "Cephalexin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "Fenoprofen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00577",
                        "description": "Valaciclovir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "Valdecoxib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "Diclofenac may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "Sulindac may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00626",
                        "description": "Bacitracin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "Amphotericin B may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00689",
                        "description": "Cephaloglycin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "Flurbiprofen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00718",
                        "description": "Adefovir dipivoxil may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "Pentamidine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "Mannitol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "Etodolac may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "Mefenamic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "Acyclovir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Naproxen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "Sulfasalazine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "Phenylbutazone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "Meloxicam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "Carprofen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "Cefaclor may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "Diflunisal may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "Tacrolimus may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "Etacrynic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00923",
                        "description": "Ceforanide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "Salicylic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "Meclofenamic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "Acetylsalicylic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "Carboplatin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "Oxaprozin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "Hydrochlorothiazide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "Ketoprofen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "Balsalazide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "Ibuprofen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "Cefditoren may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "Atazanavir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01111",
                        "description": "Colistimethate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "Cefuroxime may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01139",
                        "description": "Cefapirin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "Cefadroxil may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01150",
                        "description": "Cefprozil may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "Ceftriaxone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "Olsalazine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "Lumiracoxib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01326",
                        "description": "Cefamandole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "Cefazolin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01328",
                        "description": "Cefonicid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01329",
                        "description": "Cefoperazone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "Cefotetan may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01331",
                        "description": "Cefoxitin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "Ceftizoxime may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "Cefradine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "Magnesium salicylate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "Salsalate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "Choline magnesium trisalicylate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01413",
                        "description": "Cefepime may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "Cefacetrile may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "Ceftibuten may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "Cefpodoxime may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "Antrafenine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "Aminophenazone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "Antipyrine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "Tiaprofenic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "Lopinavir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "Etoricoxib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02247",
                        "description": "Hydrolyzed Cephalothin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03450",
                        "description": "Cephalothin Group may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "Oxyphenbutazone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04570",
                        "description": "Latamoxef may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "Nimesulide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "Benoxaprofen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "Metamizole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "Zomepirac may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04918",
                        "description": "Ceftobiprole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "Cimicoxib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06590",
                        "description": "Ceftaroline fosamil may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "Lornoxicam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "Aceclofenac may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "Zaltoprofen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "Azapropazone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "Parecoxib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "Salicylamide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "Kebuzone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "Isoxicam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "Indoprofen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "Ibuproxam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "Floctafenine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "Fenbufen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "Etofenamate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "Epirizole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "Cefaloridine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09062",
                        "description": "Cefminox may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "Benzydamine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "Dexibuprofen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "Dexketoprofen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "Droxicam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Tolfenamic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "Firocoxib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "Clonixin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "Morniflumate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "Propacetamol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "Talniflumate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "Tenofovir alafenamide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "Cefroxadine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "Robenacoxib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "Tepoxalin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "Flunixin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11935",
                        "description": "Flomoxef may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12151",
                        "description": "Brincidofovir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "Nitroaspirin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "Indobufen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "Tinoridine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "Alclofenac may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "Fentiazac may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "Suxibuzone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13266",
                        "description": "Cefatrizine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "Bumadizone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "Alminoprofen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "Difenpiramide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "Nifenazone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "Lonazolac may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13461",
                        "description": "Cefcapene may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13470",
                        "description": "Cefodizime may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "Tenidap may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13499",
                        "description": "Cefsulodin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13504",
                        "description": "Cefetamet may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "Propyphenazone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "Proglumetacin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "Guacetisal may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "Ethenzamide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "Carbaspirin calcium may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "Mofebutazone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13638",
                        "description": "Cefbuperazone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "Proquazone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "Benorilate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13667",
                        "description": "Cefozopran may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13682",
                        "description": "Cefpirome may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "Pirprofen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13778",
                        "description": "Cefazedone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "Acemetacin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13821",
                        "description": "Ceftezole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "Imidazole salicylate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13868",
                        "description": "Adefovir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "SC 236 may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "NS 398 may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "Tenofovir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "Inotersen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01438",
                        "description": "Phenazopyridine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "Givosiran may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "Lithium cation may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "Lithium citrate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "Loxoprofen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00452",
                        "description": "Framycetin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01421",
                        "description": "Paromomycin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04263",
                        "description": "Geneticin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04626",
                        "description": "Apramycin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04808",
                        "description": "Neamine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "Puromycin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11512",
                        "description": "Dihydrostreptomycin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11520",
                        "description": "Hygromycin B may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "Leuprolide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "Goserelin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "Salmon calcitonin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "Desmopressin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "Aldesleukin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "Daptomycin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "Tositumomab may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00115",
                        "description": "Cyanocobalamin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "Folic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00165",
                        "description": "Pyridoxine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "Fluvoxamine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "Baclofen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Amphetamine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "Cevimeline may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "Lorazepam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "Carbidopa may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "Tramadol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "Fluconazole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00198",
                        "description": "Oseltamivir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00200",
                        "description": "Hydroxocobalamin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "Reserpine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "Ticlopidine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Pantoprazole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00225",
                        "description": "Gadodiamide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "Temazepam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "Butabarbital may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "Benzatropine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "Doxycycline may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "Carmustine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00271",
                        "description": "Diatrizoate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "Topiramate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "Liothyronine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Disopyramide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "Acarbose may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "Venlafaxine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Conjugated estrogens may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "Atomoxetine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "Bleomycin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "Etomidate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "Etonogestrel may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "Ropivacaine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00303",
                        "description": "Ertapenem may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "Ibutilide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "Pentobarbital may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "Acetaminophen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "Piperacillin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "Floxuridine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "Tolcapone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "Hydromorphone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00330",
                        "description": "Ethambutol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "Metformin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "Methadone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00339",
                        "description": "Pyrazinamide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "Cetirizine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "Clobazam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "Megestrol acetate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00355",
                        "description": "Aztreonam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "Chlorzoxazone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "Sulfadiazine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "Clozapine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "Sucralfate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Thiethylperazine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "Palonosetron may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "Dexrazoxane may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "Sorafenib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "Eszopiclone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "Alprazolam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Pramipexole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00415",
                        "description": "Ampicillin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "Secobarbital may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Methylphenidate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "Trifluridine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "Allopurinol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "Trimethoprim may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "Gemcitabine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "Duloxetine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "Chlorpromazine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "Lenalidomide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "Buspirone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "Flutamide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "Cimetidine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "Haloperidol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "Cefdinir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "Ciprofloxacin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00548",
                        "description": "Azelaic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00553",
                        "description": "Methoxsalen may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Lamotrigine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00558",
                        "description": "Zanamivir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "Fondaparinux may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "Levocarnitine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "Fluocinolone acetonide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00597",
                        "description": "Gadoteridol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "Medroxyprogesterone acetate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "Chloroquine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Testosterone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "Clorazepic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "Clofarabine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "Dexmedetomidine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "Prednisone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Mecamylamine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "Metaxalone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "Nilutamide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "Chlorpropamide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "Midazolam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Mycophenolate mofetil may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "Flurazepam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Nitrofurantoin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "Tamsulosin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "Lamivudine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00713",
                        "description": "Oxacillin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00716",
                        "description": "Nedocromil may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00730",
                        "description": "Thiabendazole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "Nateglinide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00733",
                        "description": "Pralidoxime may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "Gadobenic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "Tetracycline may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00760",
                        "description": "Meropenem may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00761",
                        "description": "Potassium chloride may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "Methimazole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "Tirofiban may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "Phenelzine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Propantheline may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00789",
                        "description": "Gadopentetic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Dicyclomine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00811",
                        "description": "Ribavirin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00828",
                        "description": "Fosfomycin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "Diazepam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "Tolazamide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "Dobutamine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "Oxazepam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "Dacarbazine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "Temozolomide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "Ranitidine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "Terbutaline may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00894",
                        "description": "Testolactone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "Triazolam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Didanosine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00911",
                        "description": "Tinidazole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "Amantadine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "Almotriptan may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "Azacitidine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "Maprotiline may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "Isoniazid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Rizatriptan may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00961",
                        "description": "Mepivacaine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "Zaleplon may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Methyldopa may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "Ramelteon may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "Dopamine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "Azathioprine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00995",
                        "description": "Auranofin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "Salbutamol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "Levobupivacaine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "Ganciclovir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "Edrophonium may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01011",
                        "description": "Metyrapone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "Sulfamethoxazole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Guanfacine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01022",
                        "description": "Phylloquinone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "Mycophenolic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "Topotecan may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "Probenecid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "Tolterodine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "Fenofibrate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Memantine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "Lubiprostone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01048",
                        "description": "Abacavir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01060",
                        "description": "Amoxicillin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Glipizide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "Clonazepam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Promethazine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "Dimethyl sulfoxide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "Flucytosine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "Capecitabine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "Sibutramine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "Tolbutamide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "Rabeprazole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "Tiludronic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "Doxacurium may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "Levofloxacin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Flavoxate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "Nefazodone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "Bupropion may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01157",
                        "description": "Trimetrexate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "Arsenic trioxide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Guanethidine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "Ifosfamide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "Naloxone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01205",
                        "description": "Flumazenil may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01213",
                        "description": "Fomepizole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "Estazolam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "Budesonide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "Quetiapine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "Metoclopramide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "Gemfibrozil may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01249",
                        "description": "Iodixanol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "Sitagliptin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "Paliperidone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "Varenicline may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "Arformoterol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "Rasagiline may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "Colchicine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Tiotropium may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "Testosterone propionate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01428",
                        "description": "Oxybenzone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "Allylestrenol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01550",
                        "description": "Fenproporex may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "Bromazepam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "Chloral hydrate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Metamfetamine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "Ketazolam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01610",
                        "description": "Valganciclovir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "Sorbitol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Roflumilast may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "Topiroxostat may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "Estrone sulfate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "Lorcaserin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "Pegaptanib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "Milnacipran may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "Lofexidine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "Ezogabine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05018",
                        "description": "Migalastat may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "Brivaracetam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "Apremilast may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "Ipilimumab may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06196",
                        "description": "Icatibant may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "Alogliptin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "Prasugrel may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06211",
                        "description": "Doripenem may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "Rivaroxaban may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06230",
                        "description": "Nalmefene may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "Droxidopa may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "Levocetirizine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "Saxagliptin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "Telavancin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "Prucalopride may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06623",
                        "description": "Flupirtine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06637",
                        "description": "Dalfampridine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Dabigatran etexilate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "Desvenlafaxine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Fesoterodine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06705",
                        "description": "Gadofosveset trisodium may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06710",
                        "description": "Methyltestosterone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06767",
                        "description": "Ammonium chloride may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06782",
                        "description": "Dimercaprol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06796",
                        "description": "Mangafodipir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06800",
                        "description": "Methylnaltrexone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06809",
                        "description": "Plerixafor may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "Pralatrexate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06823",
                        "description": "Tiopronin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Triethylenetetramine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08824",
                        "description": "Ioflupane I 123 may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08826",
                        "description": "Deferiprone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08840",
                        "description": "N methylnicotinamide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "Gabapentin enacarbil may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "Ruxolitinib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "Mirabegron may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "Peginesatide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Aclidinium may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "Enzalutamide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08900",
                        "description": "Teduglutide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "Certolizumab pegol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "Formestane may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "Glycerol phenylbutyrate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "Pomalidomide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "Trametinib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "Levomilnacipran may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "Sofosbuvir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "Ledipasvir may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09050",
                        "description": "Ceftolozane may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09066",
                        "description": "Corifollitropin alfa may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "Vortioxetine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "Tasimelteon may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "Edoxaban may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09081",
                        "description": "Idebenone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "Vilanterol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Trimebutine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "Tixocortol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09103",
                        "description": "Ancestim may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Magnesium hydroxide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09106",
                        "description": "Hydroxyethyl Starch may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09111",
                        "description": "Pentastarch may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "Stiripentol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09121",
                        "description": "Aurothioglucose may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "Dienogest may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09129",
                        "description": "Chromic chloride may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09132",
                        "description": "Gadoteric acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09133",
                        "description": "Iothalamic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09134",
                        "description": "Ioversol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09135",
                        "description": "Ioxilan may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09136",
                        "description": "Isosulfan blue may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09137",
                        "description": "Technetium Tc 99m mebrofenin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "Technetium Tc 99m oxidronate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09148",
                        "description": "Florbetaben 18F may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09149",
                        "description": "Florbetapir 18F may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09156",
                        "description": "Iopromide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09163",
                        "description": "Technetium Tc 99m exametazime may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09165",
                        "description": "Technetium Tc 99m pyrophosphate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "Viloxazine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "Etoperidone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "Lorpiprazole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09209",
                        "description": "Pholcodine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09210",
                        "description": "Piracetam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "Bisoxatin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "Blonanserin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "Melperone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Methylene blue may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "Pirlindole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "Toloxatone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "Dextran may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "Tegafur may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09257",
                        "description": "Gimeracil may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Imidafenacin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "Idarucizumab may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "Lixisenatide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "Picosulfuric acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "Sodium aurothiomalate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09277",
                        "description": "Choline C 11 may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "Magnesium trisilicate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "Sacubitril may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09301",
                        "description": "Chondroitin sulfate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Synthetic Conjugated Estrogens A may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Synthetic Conjugated Estrogens B may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09320",
                        "description": "Procaine benzylpenicillin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09324",
                        "description": "Sulbactam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09325",
                        "description": "Sodium fluoride may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "Antihemophilic Factor Recombinant PEGylated may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09344",
                        "description": "Invert sugar may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09357",
                        "description": "Dexpanthenol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09394",
                        "description": "Phosphoric acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09395",
                        "description": "Sodium acetate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "Magnesium chloride may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "Potassium perchlorate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "Sodium sulfate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Magnesium carbonate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "Acrivastine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09496",
                        "description": "Octinoxate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09502",
                        "description": "Fludeoxyglucose 18F may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09546",
                        "description": "Iobenguane sulfate I 123 may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "Ixazomib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "Polyethylene glycol 400 may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11090",
                        "description": "Potassium nitrate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11098",
                        "description": "Potassium bicarbonate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11102",
                        "description": "N acetyltyrosine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11114",
                        "description": "Eucalyptus oil may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11127",
                        "description": "Selenious acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "Opium may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11135",
                        "description": "Selenium may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11136",
                        "description": "Chromium may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11145",
                        "description": "Oxyquinoline may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "Pyrantel may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11164",
                        "description": "Bicisate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11251",
                        "description": "Tocopherol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "DL Methylephedrine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11328",
                        "description": "Tetradecyl hydrogen sulfate ester may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11338",
                        "description": "Clove oil may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11358",
                        "description": "Evening primrose oil may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11364",
                        "description": "Pidotimod may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "Lesinurad may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11577",
                        "description": "Indigotindisulfonic acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "Etafedrine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "Antithrombin III human may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Pitolisant may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11691",
                        "description": "Naldemedine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Tropisetron may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "Baricitinib may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "Apalutamide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "Valbenazine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "Delafloxacin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11989",
                        "description": "Benznidazole may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12007",
                        "description": "Isoflavone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12107",
                        "description": "Vaborbactam may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "Deutetrabenazine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Propiverine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12783",
                        "description": "Benserazide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "Tiapride may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "Levosalbutamol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13156",
                        "description": "Inosine pranobex may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13178",
                        "description": "Inositol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13185",
                        "description": "Oxabolone cipionate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13191",
                        "description": "Phosphocreatine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13269",
                        "description": "Dichlorobenzyl alcohol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "Ipecac may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "Almasilate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "Fenofibric acid may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "Albutrepenonacog alfa may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Bismuth subgallate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Testosterone cypionate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "Testosterone enanthate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Estradiol acetate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Estradiol cypionate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "Estradiol dienanthate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Estradiol valerate may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "Patent Blue may decrease the excretion rate of Choline salicylate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14007",
                        "description": "Patent Blue may decrease the excretion rate of Pentetic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14498",
                        "description": "Patent Blue may decrease the excretion rate of Potassium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "Patent Blue may decrease the excretion rate of Potassium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14526",
                        "description": "Patent Blue may decrease the excretion rate of Chromic citrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14527",
                        "description": "Patent Blue may decrease the excretion rate of Chromic nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14528",
                        "description": "Patent Blue may decrease the excretion rate of Chromium gluconate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14529",
                        "description": "Patent Blue may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14530",
                        "description": "Patent Blue may decrease the excretion rate of Chromous sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "Patent Blue may decrease the excretion rate of Solriamfetol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06815",
                        "description": "Pyrithione may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11121",
                        "description": "Chloroxylenol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11085",
                        "description": "Resorcinol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15593",
                        "description": "Patent Blue may decrease the excretion rate of Golodirsen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "Amitriptyline may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "Imipramine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Doxepin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "Codeine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "Meperidine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "Fentanyl may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00879",
                        "description": "Emtricitabine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "Desipramine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "Clomipramine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "Dimetacrine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14506",
                        "description": "Patent Blue may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13987",
                        "description": "Patent Blue may decrease the excretion rate of Strontium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04890",
                        "description": "Bepotastine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "Isotretinoin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04930",
                        "description": "Permethrin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "Difluocortolone may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00479",
                        "description": "Amikacin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00684",
                        "description": "Tobramycin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00798",
                        "description": "Gentamicin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00955",
                        "description": "Netilmicin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "Neomycin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01082",
                        "description": "Streptomycin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01172",
                        "description": "Kanamycin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03615",
                        "description": "Ribostamycin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04729",
                        "description": "Gentamicin C1a may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06696",
                        "description": "Arbekacin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12604",
                        "description": "Sisomicin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13540",
                        "description": "Isepamicin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "Pentostatin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13145",
                        "description": "Nedaplatin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "Patent Blue may decrease the excretion rate of Capreomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Patent Blue may decrease the excretion rate of Digoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "Patent Blue may decrease the excretion rate of Vancomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "Patent Blue may decrease the excretion rate of Cisplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "Patent Blue may decrease the excretion rate of Carbamazepine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "Patent Blue may decrease the excretion rate of Pemetrexed which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "Patent Blue may decrease the excretion rate of Warfarin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Patent Blue may decrease the excretion rate of Quinidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Patent Blue may decrease the excretion rate of Procainamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "Patent Blue may decrease the excretion rate of Plazomicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "Patent Blue may decrease the excretion rate of Lithium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00803",
                        "description": "Colistin may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Metolazone may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Furosemide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "Indapamide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "Bumetanide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "Zonisamide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "Canagliflozin may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09338",
                        "description": "Mersalyl may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Torasemide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "Methyclothiazide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Chlorthalidone may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "Ethoxzolamide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "Spironolactone may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Bendroflumethiazide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "Benzthiazide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "Amiloride may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Cyclothiazide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Eplerenone may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "Methazolamide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Hydroflumethiazide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "Acetazolamide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "Conivaptan may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Chlorothiazide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Trichlormethiazide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "Diclofenamide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Polythiazide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "Quinethazone may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "Drospirenone may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "Piretanide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Tienilic acid may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05034",
                        "description": "Ularitide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "Tolvaptan may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "Dapagliflozin may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "Indisulam may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "Azosemide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "Canrenoic acid may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "Potassium citrate may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "Ertugliflozin may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "Canrenone may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12670",
                        "description": "Rolofylline may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Spiradoline may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Cicletanine may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13284",
                        "description": "Meticrane may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13405",
                        "description": "Mefruside may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "Mebutizide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Cyclopenthiazide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13617",
                        "description": "Clorexolone may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13663",
                        "description": "Clofenamide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13708",
                        "description": "Fenquizone may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13792",
                        "description": "Clopamide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Muzolimine may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Xipamide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "Epitizide may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "Bromotheophylline may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "Potassium may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "Potassium cation may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}